HowardPeterChaseMD
Pediatric Endocrinology • Aurora, COProfessor, Pediatrics, University of Colorado School of Medicine
Are you Dr. Chase?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 15 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1775 Aurora Ct
Aurora, CO 80045Phone+1 720-724-2323
Summary
- Dr. Howard Chase, MD is a pediatric endocrinologist in Aurora, Colorado. He is currently licensed to practice medicine in Colorado. He is a Professor at University of Colorado School of Medicine.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Pediatrics, 1962 - 1964
University of Utah HealthInternship, Pediatrics, 1961 - 1962
University of Wisconsin School of Medicine & Public HealthClass of 1961
Certifications & Licensure
CO State Medical License 1970 - 2019
Clinical Trials
- Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus Start of enrollment: 2007 Feb 01
Publications & Presentations
PubMed
- 938 citationsContinuous glucose monitoring and intensive treatment of type 1 diabetes.William V. Tamborlane, Roy W. Beck, Bruce W. Bode, Bruce A. Buckingham, Chase Hp
The New England Journal of Medicine. 2008-10-02 - 16 citationsPredictive hyperglycemia and hypoglycemia minimization: In‐home double‐blind randomized controlled evaluation in children and young adolescentsGregory P. Forlenza, Dan Raghinaru, Faye Cameron, B. Wayne Bequette, H. Peter Chase
Pediatric Diabetes. 2018-05-01 - 68 citationsOutpatient Safety Assessment of an In-Home Predictive Low-Glucose Suspend System with Type 1 Diabetes Subjects at Elevated Risk of Nocturnal HypoglycemiaBruce A. Buckingham, Fraser Cameron, Peter Calhoun, David M. Maahs, Darrell M. Wilson
Diabetes Technology & Therapeutics. 2013-08-12
Press Mentions
Guiding Inventions from Lab to MarketFebruary 1st, 2021
